去年，Quest Diagnostics Inc表現最佳的業務類別Routine clinical testing services的營收達到5.96B美元。United States的營收貢獻最高，去年達到11.04B美元。最近一個季度，截至2023-12-31，Quest Diagnostics Inc表現最佳的業務類別Routine clinical testing services的營收達到1.24B美元。United States的營收貢獻最高，達到2.90B美元。

業務

營業收入

佔比

年報

年報

單季報

Routine clinical testing services

Gene-based and esoteric testing services

Anatomic pathology testing services

All other

COVID-19 testing services

All other

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

Routine clinical testing services

5.96B(54.00%)

5.03B(51.00%)

4.72B(51.00%)

4.35B(44.00%)

4.29B(39.79%)

3.84B(40.65%)

4.21B(54.44%)

4.22B(56.00%)

Gene-based and esoteric testing services

4.19B(38.00%)

3.85B(39.00%)

3.52B(38.00%)

3.16B(32.00%)

2.88B(26.68%)

2.10B(22.23%)

2.62B(33.91%)

2.41B(31.99%)

Anatomic pathology testing services

662.10M(6.00%)

592.32M(6.00%)

555.12M(6.00%)

592.98M(6.00%)

553.00M(5.13%)

482.00M(5.11%)

579.00M(7.49%)

578.00M(7.67%)

All other

220.70M(2.00%)

--(--)

COVID-19 testing services

--(--)

98.72M(1.00%)

185.04M(2.00%)

1.48B(15.00%)

2.77B(25.68%)

2.72B(28.85%)

--(--)

All other

--(--)

296.16M(3.00%)

277.56M(3.00%)

296.49M(3.00%)

294.00M(2.73%)

298.00M(3.16%)

321.00M(4.15%)

327.00M(4.34%)

地區

營業收入

佔比

年報

年報

單季報

United States

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

United States

11.04B(100.00%)

9.87B(100.00%)

9.25B(100.00%)

9.88B(100.00%)

10.79B(100.00%)

9.44B(100.00%)

7.73B(100.00%)